Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin α5β1/FAK/p53 signaling pathway
Authors
Keywords
Chenodeoxycholic acid, Integrin, FAK, Lung adenocarcinoma
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 923, Issue -, Pages 174925
Publisher
Elsevier BV
Online
2022-03-30
DOI
10.1016/j.ejphar.2022.174925
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hidden RNA pairings counteract the “first-come, first-served” splicing principle to drive stochastic choice in Dscam1 splice variants
- (2022) Haiyang Dong et al. Science Advances
- CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer
- (2021) Jianjie Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
- (2021) Flavio Ballante et al. PHARMACOLOGICAL REVIEWS
- An expert overview of emerging therapies for acute myeloid leukemia: novel small molecules targeting apoptosis, p53, transcriptional regulation and metabolism
- (2020) Kapil Saxena et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Divergence of the PIERCE1 expression between mice and humans as a p53 target gene
- (2020) Hye Jeong Kim et al. PLoS One
- Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
- (2020) Suyanee Thongchot et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration
- (2020) Zu-Jun Que et al. JOURNAL OF ETHNOPHARMACOLOGY
- Abnormally activated OPN/integrin αVβ3/FAK signalling is responsible for EGFR-TKI resistance in EGFR mutant non-small-cell lung cancer
- (2020) Yulong Fu et al. Journal of Hematology & Oncology
- The tumor suppressor p53 can promote collective cellular migration
- (2019) Shijie He et al. PLoS One
- Genotype Driven Therapy for Non-Small Cell Lung Cancer: Resistance, Pan Inhibitors and Immunotherapy
- (2019) Sitanshu S. Singh et al. CURRENT MEDICINAL CHEMISTRY
- The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review
- (2019) Jin Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma
- (2019) Shaohui He et al. BRITISH JOURNAL OF CANCER
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Integrins as A New Target for Cancer Treatment
- (2018) Izabela Lasinska et al. Anti-Cancer Agents in Medicinal Chemistry
- SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
- (2017) Yanlu Xiong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice
- (2017) Ning Zhang et al. MOLECULAR PHARMACEUTICS
- ING5 knockdown enhances migration and invasion of lung cancer cells by inducing EMT via EGFR/PI3K/Akt and IL-6/STAT3 signaling pathways
- (2017) Xin-Li Liu et al. Oncotarget
- Molecular Pathways: Endothelial Cell FAK--A Target for Cancer Treatment
- (2016) M. Roy-Luzarraga et al. CLINICAL CANCER RESEARCH
- Lung cancer and metastasis: new opportunities and challenges
- (2015) Xiangdong Wang et al. CANCER AND METASTASIS REVIEWS
- Mechanisms of p53 degradation
- (2015) Chuck C.-K. Chao CLINICA CHIMICA ACTA
- The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes
- (2015) Alexander Marx et al. Journal of Thoracic Oncology
- Therapeutic Effect of Chenodeoxycholic Acid in an Experimental Rabbit Model of Osteoarthritis
- (2015) Zhao-wei Yan et al. MEDIATORS OF INFLAMMATION
- Integrins and Integrin-Associated Proteins in the Cardiac Myocyte
- (2014) Sharon Israeli-Rosenberg et al. CIRCULATION RESEARCH
- Design, synthesis, and biological evaluation of novel FAK scaffold inhibitors targeting the FAK–VEGFR3 protein–protein interaction
- (2014) Priyanka N. Gogate et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy
- (2012) Wen Wee Ma Anti-Cancer Agents in Medicinal Chemistry
- Deoxycholic and chenodeoxycholic bile acids induce apoptosis via oxidative stress in human colon adenocarcinoma cells
- (2011) Juan Ignacio Barrasa et al. APOPTOSIS
- Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
- (2011) C Giordano et al. ONCOGENE
- Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA
- (2010) Jie Ding et al. NATURE CELL BIOLOGY
- A new bile acid from the bile ofAnser anser
- (2009) Zhao-Wei Yan et al. NATURAL PRODUCT RESEARCH
- A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells
- (2008) Sang Eun Park et al. CANCER LETTERS
- Characterization of Enantiomeric Bile Acid-induced Apoptosis in Colon Cancer Cell Lines
- (2008) Bryson W. Katona et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Nuclear FAK Promotes Cell Proliferation and Survival through FERM-Enhanced p53 Degradation
- (2008) Ssang-Taek Lim et al. MOLECULAR CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started